Literature DB >> 26108905

[Neuropsychological deficits in alternating hemiplegia of childhood: a case study].

Vega Muriel1, Alberto Garcia-Molina, Celeste Aparicio-Lopez, Antònia Ensenat, Teresa Roig-Rovira.   

Abstract

INTRODUCTION: Alternating hemiplegic of childhood is a predominantly sporadic neurodevelopmental syndrome of uncertain etiology, characterized by alternating transient attacks of hemiplegia. Additional features include tonic fits, dystonic posturing, ocular motor abnormalities and deficits in cognitive functioning. CASE REPORT: A girl of 7 years-old with alternating hemiplegic of childhood. The first symptoms debut at 17 months of age in the form of lower limb weakness, migraine, nystagmus and hemiplegic crisis alternating both hemibodies. We administrate the Wechsler Intelligence Scale for Children IV (WISC-IV), the Conners Continuous Performance Test II (CPT-II), the Conners scales for parents (CPRS-48) and teachers (CTRS-28) and the Behavior Rating Inventory Executive Function (BRIEF).
CONCLUSIONS: In our study we found deficits in sustained attention, reduced speed of information processing, and difficulties in understanding, speaking and working memory. In addition, parents and teachers reported behavioral disturbances, difficulties inhibition capability, in self-control and in regulating emotions.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26108905

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  2 in total

1.  Deficits in social behavioral tests in a mouse model of alternating hemiplegia of childhood.

Authors:  Greer S Kirshenbaum; Nagi F Idris; James Dachtler; John C Roder; Steven J Clapcote
Journal:  J Neurogenet       Date:  2016-03       Impact factor: 1.250

2.  Missense variants in ATP1A3 and FXYD gene family are associated with childhood-onset schizophrenia.

Authors:  Boris Chaumette; Vladimir Ferrafiat; Amirthagowri Ambalavanan; Alice Goldenberg; Alexandre Dionne-Laporte; Dan Spiegelman; Patrick A Dion; Priscille Gerardin; Claudine Laurent; David Cohen; Judith Rapoport; Guy A Rouleau
Journal:  Mol Psychiatry       Date:  2018-06-12       Impact factor: 15.992

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.